All News
Can "Ultra-low" dose Rituximab work for RA?
The REDO trial presented data in abstract 1443 in an oral presentation challenging how low we can go with rituximab for rheumatoid arthritis. Their study randomized 118 patients with rheumatoid arthritis to 1000 mg, 500 mg, and "ultra-low" dose 200 mg.
Read Article
Depression in Axial Spondyloarthritis: Dr. Mrinalini Dey ( @DrMiniDey) discusses abstract #1305 presented at the #ACR21 annual meeting.
https://t.co/KUGM61fpZK https://t.co/YhyvGUJkO0
Links:
Dr. John Cush RheumNow ( View Tweet)
#ACR21 – Day 3 Report
Day 3 presentations were big! We share a few of our favorites.
https://t.co/UfWIFq2lWb https://t.co/Z8VKGXvPzz
Links:
Dr. John Cush RheumNow ( View Tweet)
Monitoring Infliximab Drug Levels Improves Efficacy
Should we start considering therapeutic drug monitoring when prescribing TNFi for treatment of our rheumatologic conditions?
Dr. Robert Chao ( @doctorRBC) shares data presented at #ACR21.
https://t.co/IJ9by2iguK https://t.co/KBIWTs9iPV
Links:
Dr. John Cush RheumNow ( View Tweet)
Hypertension in AS: Drs. Swetha Ann Alexander ( @swethaann23) interviews Dr. Jean Liew about abstract #0910, presented Sunday at the #ACR21 annual meeting.
https://t.co/3oHnLbQAl8 https://t.co/dwxlb4GSzb
Links:
Dr. John Cush RheumNow ( View Tweet)
Pulse Pressure as a Predictor of Carotid Plaque in RA: Dr. Meral El Ramahi ( @MeralElRamahiMD ) discusses abstract #0276 presented at the #ACR21 annual meeting.
https://t.co/TkWJ2ehgma https://t.co/6OoTLKlQ1H
Links:
Dr. John Cush RheumNow ( View Tweet)
NrAxSpA progression to AxSpA: Dr. Rachel Tate ( @uptoTate) discusses non-radiographic Axial Spondyloarthritis and progression to AS, data from Abstract #0907 presented at the #ACR21 annual meeting.
https://t.co/GXJMJ5D9vG https://t.co/JWiQakf30E
Links:
Dr. John Cush RheumNow ( View Tweet)
More severe COVID-19 outcomes in African American, Hispanic individuals with SLE
A study from #ACR21 discussing data from the GRA describes the association between race/ethnicity on COVID-19 outcomes specifically in lupus patients (Abstract #1933).
https://t.co/3X7wydVCQR https://t.co/NNbaM0njTX
Links:
Dr. John Cush RheumNow ( View Tweet)
To Clot or Not to Clot with Drs. Janet Pope ( @Janetbirdope) and Jeffrey Sparks ( @jeffsparks )
#ACR21
https://t.co/vfOGgTflfl https://t.co/V9cBGAnGnN
Links:
Dr. John Cush RheumNow ( View Tweet)
Risks associated with mortality in VEXAS
Dr. Md Yuzaiful Md Yusof ( @Yuz6Yusof) shares findings from abstracts presented at #ACR21.
https://t.co/BgYrOaraXC https://t.co/KYLjpi8baP
Links:
Dr. John Cush RheumNow ( View Tweet)
Best of PsA Saturday: Dr Rachel Tate ( @uptoTate) discusses "best of" abstracts - #0488, #0453 and #0064 - presented Saturday, at the #ACR21 annual meeting.
https://t.co/nMUH6yJTmo https://t.co/x5htYZHq3v
Links:
Dr. John Cush RheumNow ( View Tweet)
Telemedicine Enriched Care Model for Autoinflammatory Diseases
Dr. Bella Mehta ( @bella_mehta) shares how creative solutions to improve access of our patients with rare diseases may help early diagnoses, decrease complications/ improve outcomes. #ACR21
https://t.co/DM5Qtoj5RD https://t.co/Ruu22maEbn
Links:
Dr. John Cush RheumNow ( View Tweet)
11 Ways to Stay Away From RA: Dr. David Liew ( @drdavidliew ) weighs in on abstracts presented at #ACR21.
https://t.co/wRTXvXfosA https://t.co/cXDRLpaPwB
Links:
Dr. John Cush RheumNow ( View Tweet)
Tired of Doing Nothing About Fatigue: Dr. David Liew ( @drdavidliew ) discusses abstract #0462 presented at the #ACR21 annual meeting.
https://t.co/jEUVNNAVsL https://t.co/uwSymr8xuh
Links:
Dr. John Cush RheumNow ( View Tweet)
The Need for Comparative Treatment Trials in Psoriatic Arthritis
Dr. Richard Conway ( @RichardPAConway) discusses a small sample of novel agents demonstrating efficacy in PsA presented at #ACR21, we have Abs #453, Abs #488, and Abstract #490.
https://t.co/eXBN1XFhRl https://t.co/McxpwTse16
Links:
Dr. John Cush RheumNow ( View Tweet)
Treating RA: Does Where You Live Matter? Dr. Mrinalini Dey ( @DrMiniDey ) discusses abstract #0494 presented at the #ACR21 annual meeting.
https://t.co/xqKSPKelCQ https://t.co/Q6UKuExnwV
Links:
Dr. John Cush RheumNow ( View Tweet)
Best of Spondyloarthritis from Day 1: Dr. Robert Chao ( @doctorRBC) reviews some of the best abstracts he saw on day 1 (Saturday) presented at the #ACR21 annual meeting, including abstracts #0068 and #0062.
https://t.co/qzPiXqzOWe https://t.co/6LX5iPtcJR
Links:
Dr. John Cush RheumNow ( View Tweet)
New Insights into Uveitis in Spondyloarthritis
There have been some updates on uveitis in SpA at #ACR21 shared by Dr. Antoni Chan ( @synovialjoints).
https://t.co/cl2CvWzTcv https://t.co/v4FltWUEH6
Links:
Dr. John Cush RheumNow ( View Tweet)
#ACR21 Best Abstracts We Saw - Day 3 (Monday)
The third day of ACR 2021 took a big leap in online content. We share compilation (with links) of presentations were the “ACRBest” as seen by our RheumNow faculty.
https://t.co/kQlLZwBDH6 https://t.co/rkVhpbLkwR
Links:
Dr. John Cush RheumNow ( View Tweet)
Recognizing and Treating Axial Disease in Psoriatic Arthritis: Dr. Pedro Castillo ( @_Castillo_Pedro) reviews highlights from an #ACR21 session, Session 6S403, presented at the ACR21 annual meeting.
https://t.co/9FOfmAI8Gs https://t.co/kiLesu72yI
Links:
Dr. John Cush RheumNow ( View Tweet)